$393.000 value
$110.00 (15%
off)VIPapplied$393.000
Boston Scientific’s global footprint in emerging markets is a tailwind in the BSX stock forecast, with double‑digit growth reported in Asia-Pacific device sales. Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped: Smart Portfolio is supported by our partner TipRanks. By connecting my portfolio to TipRanks Smart Portfolio I agree to their Terms of Use . The latest BSX stock forecast points to steady momentum, with analysts eyeing a potential upside toward the $68–$72 range over the next quarter. Boston Scientific continues to benefit from robust demand in cardiology devices, supported by Q1 revenue growth exceeding 14% year-over-year.
Offers & perks
Join Star Rewards & get
free shipping at $39
Exclusions